3,3'-(2-methyl-5-nitropyrimidine-4,6-diyl)bis(3,6,9,12-tetraazadispiro[5.2.59.26]hexadecane-6,9-diium) Tetrachloride Hexahydrate

ID: ALA5220957

Chembl Id: CHEMBL5220957

PubChem CID: 168299353

Max Phase: Preclinical

Molecular Formula: C29H66Cl4N11O8+

Molecular Weight: 587.82

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nc(N2CC[N+]3(CC2)CC[N+]2(CCNCC2)CC3)c([N+](=O)[O-])c(N2CC[N+]3(CC2)CC[N+]2(CCNCC2)CC3)n1.Cl.O.O.O.O.O.O.[Cl-].[Cl-].[Cl-]

Standard InChI:  InChI=1S/C29H53N11O2.4ClH.6H2O/c1-26-32-28(34-6-14-39(15-7-34)22-18-37(19-23-39)10-2-30-3-11-37)27(36(41)42)29(33-26)35-8-16-40(17-9-35)24-20-38(21-25-40)12-4-31-5-13-38;;;;;;;;;;/h30-31H,2-25H2,1H3;4*1H;6*1H2/q+4;;;;;;;;;;/p-3

Standard InChI Key:  OCWOGLALYATAHX-UHFFFAOYSA-K

Associated Targets(non-human)

Human alphaherpesvirus 1 (11089 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Coxsackievirus B3 (1096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 587.82Molecular Weight (Monoisotopic): 587.4362AlogP: -1.17#Rotatable Bonds: 3
Polar Surface Area: 99.46Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 6.13CX LogP: -16.85CX LogD: -16.87
Aromatic Rings: 1Heavy Atoms: 42QED Weighted: 0.26Np Likeness Score: -0.45

References

1. Egorova A, Bogner E, Novoselova E, Zorn KM, Ekins S, Makarov V..  (2021)  Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review).,  211  [PMID:33218683] [10.1016/j.ejmech.2020.113014]

Source